patient safety

Patients with active cancer who experienced blood clots, known medically as venous thromboembolism (VTE), showed favorable outcomes with a lower dose of apixaban. This was demonstrated by the recent API-CAT trial, which found that a reduced dose effectively prevented recurrence of VTE while substantially lowering the risk of bleeding, compared to the standard higher dose.

In a groundbreaking development for accessibility and consumer technology, Apple has rolled out a major update to its AirPods Pro 2 in Australia that allows the popular wireless headphones to function as over-the-counter hearing aids for individuals with mild to moderate hearing loss. Approved by the Therapeutic Goods Administration (TGA) in December 2024, this innovative update is set to lower the barrier to hearing support while challenging traditional perceptions about hearing aids. However, experts caution that while the new feature offers significant benefits, it is not a one-size-fits-all solution for all types or severities of hearing loss.

In a concerning pattern that continues to unfold across central Queensland, a vulnerable patient with Alzheimer's disease walked out of the care of Gladstone Hospital on Sunday morning. The incident marks the third time in less than two years that a patient has gone missing from a central Queensland public hospital, raising serious questions about the safety and security measures in place for those with cognitive impairments.

Explore the mechanisms and clinical implications of GLP-1 receptor agonists (GLP-1RAs) in managing type 2 diabetes and obesity. This article discusses the benefits of GLP-1RAs, highlights recent studies linking their use to thyroid cancer diagnoses, and emphasizes the importance of patient evaluation, education, and monitoring. Understand how to navigate the balance between therapeutic benefits and potential risks to optimize diabetes care.

This article explores GLP-1 receptor agonists, a class of medications used for type 2 diabetes and weight management. It examines their benefits, including potential cardiovascular improvements and weight loss, while also discussing associated health risks. Recent research highlights the need for diverse study populations to ensure comprehensive understanding of their effects. Future directions in obesity treatment and the importance of informed patient-provider discussions are also addressed, paving the way for personalized approaches in healthcare.